High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: Need for enhanced screening approach

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 8, 2016, Pages 1033-1039

  Henostroza, German ^a,b   Harris, J B ^a,b   Chitambi, R ^b   Siyambango, M ^b   Turnbull, E R ^a,b   Maggard, K R ^a,b   Kruuner A ^a,b   Kapata, N ^c   Reid, S E ^a,b  

^a University of Alabama at Birmingham   (United States)

^b CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^c MINISTRY OF HEALTH   (Zambia)

Author keywords

Chest X ray; Diagnosis; Xpert MTB RIF

Indexed keywords

ADULT; ARTICLE; BLOOD CULTURE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; COUGHING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FEVER; FLUORESCENCE MICROSCOPY; HEALTH CARE NEED; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NIGHT SWEAT; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; THORAX RADIOGRAPHY; TUBERCULOSIS; URINE CULTURE; VIRUS TRANSMISSION; WEIGHT REDUCTION; ZAMBIA; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROSCOPY; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SPUTUM;

ADULT; BACTERIOLOGICAL TECHNIQUES; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; SPUTUM; TUBERCULOSIS, PULMONARY; ZAMBIA;

EID: 84978285731     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.15.0651     Document Type: Article

References (27)

1. World Health Organization. Global tuberculosis report, 2015. WHO/HTM/TB/2015.22. Geneva, Switzerland: WHO, 2015.
2. UNAIDS. Zambia: HIV and AIDS estimates. Geneva, Switzerland: UNAIDS, 2014. http://www.unaids.org/en/regionscountries/countries/zambia/. Accessed April 2016.
3. Luetkemeyer AF, KendallMA, Nyirenda M, et al. Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: Timing, severity, and implications for HIV-TB programs. JAcquir Immune Defic Syndr 2014; 65: 423-428.
4. Marais S, Meintjes G, Pepper DJ, et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis 2013; 56: 450-460.
5. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosisassociated immune reconstitution disease: Incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21: 335-341.
6. Trollip S, Harris JB, Turnbull ER, et al. Tuberculosis screening practices among patients enrolled into HIV Care in Lusaka, Zambia. Paper presented at the 41st Union World Conference on Lung Health, 11-15 November 2010, Berlin, Germany. [Abstract PC-101345-13]. Int JTuberc Lung Dis 2010: 14 (Suppl 2): S64.
7. Kivihya-Ndugga LE, van Cleeff MR, Githui WA, et al. Acomprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int JTuberc Lung Dis 2003; 7: 1163-1171.
8. Prasanthi K, Kumari AR. Efficacy of fluorochrome stain in the diagnosis of pulmonary tuberculosis co-infected with HIV. Indian JMed Microbiol 2005; 23: 179-181.
9. Dawson R, Masuka P, Edwards DJ, et al. Chest radiograph reading and recording system: Evaluation for tuberculosis screening in patients with advanced HIV. Int JTuberc Lung Dis 2010; 14: 52-58.
10. Den Boon S, White NW, van Lill SW, et al. An evaluation of symptom and chest radiographic screening in tuberculosis prevalence surveys. Int JTuberc Lung Dis 2006; 10: 876-882.
11. Balabanova Y, Coker R, Fedorin I, et al. Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: Observational study. BMJ 2005; 331: 379-382.
12. World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test: Technical and operational 'how-to'; practical considerations. WHO/HTM/TB/2011.2. Geneva, Switzerland: WHO, 2011.
13. Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: Implications for tuberculosis control. Am JRespir Crit Care Med 2007; 175: 87-93.
14. Van't Hoog AH, Laserson KF, Githui WA, et al. High prevalence of pulmonary tuberculosis and inadequate case finding in rural western Kenya. Am JRespir Crit Care Med 2011; 183: 1245-1253.
15. Bassett IV, Wang B, Chetty S, et al. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 2010; 51: 823-829.
16. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration. Ann Intern Med 2003; 138: W1-W12.
17. Getahun H, KittikraisakW, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: Individual participant data meta-analysis of observational studies. PLOS Med 2011; 8: E1000391.
18. World Health Organization. Guidelines for intensified casefinding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: WHO, 2010.
19. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1- infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet 2006; 367: 817-824.
20. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: Implications for programme design. AIDS 2005; 19: 2141-2148.
21. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22: 1897-1908.
22. Lawn SD, Nicol MP. Xpertw MTB/RIF assay: Development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 2011; 6: 1067-1082.
23. McDonald LC, Archibald LK, Rheanpumikankit S, et al. Unrecognised Mycobacterium tuberculosis bacteraemia among hospital in-patients in less developed countries. Lancet 1999; 354: 1159-1163.
24. Kufa T, Mngomezulu V, Charalambous S, et al. Undiagnosed tuberculosis among HIV clinic attendees: Association with antiretroviral therapy and implications for intensified case finding, isoniazid preventive therapy, and infection control. JAcquir Immune Defic Syndr 2012; 60: E22-e28.
25. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A,Wood R. Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 2012; 54: 1071-1079.
26. Harris JB, Siyambango M, Levitan EB, et al. Derivation of a tuberculosis screening rule for sub-Saharan African prisons. Int JTuberc Lung Dis 2014; 18: 774-780.
27. Harris JB, Siyambango M, Kruuner A, et al. Role of physical exam as an adjunct to World Health Organization symptom screening in HIV-infected persons. Presented at the 43rd Union World Conference on Lung Health, Kuala Lumpur, Malaysia, 13-17 November 2012. [Abstract OP-113-15]. Int JTuberc Lung Dis 2012; 16 (Suppl 1): S79.